⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
Organon conclut un accord pour obtenir la licence de MIUDELLA®, le dispositif intra-utérin sans hormones de Sebela Pharmaceuticals
businesswire.com
OGN
オルガノン、セベラ・ファーマシューティカルズのホルモンフリー子宮内避妊具「MIUDELLA ® 」のライセンス契約を 締結
businesswire.com
OGN
Organon schließt Lizenzvereinbarung für MIUDELLA®, das hormonfreie Intrauterinpessar von Sebela Pharmaceuticals
businesswire.com
OGN
Organon sluit overeenkomst voor licentie op MIUDELLA ® , het hormoovrije spiraaltje van Sebela Pharmaceuticals
businesswire.com
OGN
Organon sluit overeenkomst voor licentie op MIUDELLA ® , het hormoovrije spiraaltje van Sebela Pharmaceuticals
businesswire.com
OGN
Organon firma acordo para licenciar MIUDELLA®, dispositivo intrauterino (DIU) sem hormônios da Sebela Pharmaceuticals
businesswire.com
OGN
Organon firma un accordo di licenza per MIUDELLA ®, il dispositivo intrauterino privo di ormoni di Sebela Pharmaceuticals
businesswire.com
OGN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
OGN
Form 8-K
sec.gov
OGN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Stockholders to Connect
accessnewswire.com
OGN